Delivery Order SPE2DX15D3202-SPE2DX24F2PR4
Award Date
8/28/24
Potential Completion Date
9/19/24
Potential Value
$6.5K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,214.03 contract is for the delivery of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TABRECTA 200 MG TABLET UU 56S, a pharmaceutical product. The contract is a firm-fixed price delivery order with a ceiling value of $14,428.06 and a performance period through July 21, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen...
This federal contract award was issued by the Medical Supply Chain, which is part of the Defense Logistics Agency (DLA) Troop Support, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,568.70 firm-fixed price delivery order is for pharmaceutical and medical supplies, with an ultimate completion date of September 25, 2024. Amerisourcebergen, a major U.S. pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This federal contract award, valued at $46,728.88, was issued by the Medical Supply Chain division of the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order with a firm fixed price, and the ultimate completion date is September 17, 2024. The award supports the supply of pharmaceutical and medical products, including prescription medications, over-the-counter drugs, and medical supplies, to...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) Troop Support. The $27,714.12 Firm Fixed Price Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract has a completion date of September 24, 2024 and is not designated as a set-aside. Amerisourcebergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other agencies, valued up...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $13,463.77 firm fixed price delivery order is for the supply of ORSERDU 345 MG TABLET 30S, a pharmaceutical product, to support healthcare requirements. The contract has an ultimate completion date of August 28, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government,...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $10,223.30 firm-fixed price delivery order, awarded on September 9, 2024, is for the supply of pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare providers. The contract has an ultimate completion date of September 10, 2024 and does not have a set-aside designation....
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $3,444.25 firm fixed-price delivery order has an ultimate completion date of August 21, 2024. The contract is not associated with a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide a variety of pharmaceutical products and medical supplies to support military treatment...
This federal contract award was issued by the Medical Supply Chain branch of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $32,996.72 firm fixed price delivery order, with a completion date of September 13, 2024, is for the supply of various pharmaceutical and medical products to support military treatment facilities and federal healthcare programs. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite...
This federal contract award, valued at $29,842.50, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of pharmaceutical and medical supplies, including a wide range of prescription medications, over-the-counter drugs, and specialty medical commodities. As a major pharmaceutical distributor, Amerisourcebergen leverages its extensive supply chain network to support...